Synthetic TLR4 agonist as a potential immunotherapy for melioidosis

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach

Introduction Selective enhancement (or activation) of the immune system by novel small molecules may be a potential therapeutic approach for the treatment of cancer. RORgt (Retinoic Acid Receptor-related orphan receptor) is the key transcription factor for the development of CD4 Th17 cells, CD8 Tc17 cells and IL-17 innate immune cells including gδ T cells. A member of the nuclear receptor super...

متن کامل

Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy

  Background: Prostate cancer is one of the leading causes of cancer deaths among men. New gene expressed in prostate (NGEP), is a prostate-specific gene expressed only in normal prostate and prostate cancer tissue. Because of its selective expression in prostate cancer cell surface, NGEP is a potential immunotherapeutic target. To target the NGEP in prostate cancer, it is essential to investig...

متن کامل

A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells

Methods B16F10-OVA melanoma bearing C57BL/6 mice were immunized with the lentiviral vector DCVex on 10 days after tumor challenge to induce OVA specific effector and memory CD8 T cells. Mice were then treated 12 days later intratumorally with the TLR4 agonist GLAAS (glucopyranosyl adjuvant system), which induces the T cell homing chemokines CXCL9 and CXCL10. Control mice received no treatment o...

متن کامل

Potential of cancer-testis antigens as targets for cancer immunotherapy

Cancer-testis antigens are tumour antigens with limited expression in male germ cells in the testis, ovary and trophoblasts. Recently, their expression has been seen in different types of tumours. Due to the existence of the blood-testis barrier, testis is considered an immune-privileged site; and testis-specific genes, if expressed in cancers, can be immunogenic. For this reason, cancertestis ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Open Journal of Immunology

سال: 2013

ISSN: 2162-450X,2162-4526

DOI: 10.4236/oji.2013.31001